ThinkGenetic, Inc. recently announced the hire of business development expert, Rene Matz, RN as Vice President of Business Development. She will be primarily responsible for collaborating with pharmaceutical, biotech companies, and labs to educate about the mission and services ThinkGenetic provides in support of the genetic disease community.
“ThinkGenetic has grown so rapidly,” explains ThinkGenetic President, Len Barker. “And with that growth has come the need for a full-time person in business development and with her experience in health care business development and passion to help patients, Rene is a dream come true. I am confident that she will carry the ThinkGenetic message to the marketplace.”
Matz joined the company in September and immediately began work educating key decision makers at pharmaceutical companies involved in the clinical research, development, and sale of treatments for genetic conditions about ThinkGenetic’s services including FindEHR™ – an electronic health record tool that utilizes machine learning to alert clinicians about patients in need of evaluation for genetic conditions.
“I immediately recognized the unique value in the technology that ThinkGenetic has created and the passionate team that has been assembled in carrying out the singular mission to decrease the time to diagnosis for those with a rare genetic disease.” explains Matz, “I am most excited about joining forces with industry partners in providing a clear path for patients that may include enrollment in clinical trials or treatment for their genetic condition.”
Ms. Matz brings over two decades of experience as a Clinical Specialist and Account Executive in the Pharmaceutical, Biologics, and Medical Device industries. Before joining ThinkGenetic in 2022, she worked in various specialties including Regenerative Medicine, Neuroscience, and Trauma/ Critical Care, both as an Executive Sales Representative and Registered Nurse Educator. She brings her passion to connect patients with the resources they so desperately need by forging relationships with industry partners who can provide the opportunity for trials and treatment in the rapidly evolving rare and genetic disease space. In her previous role as an Executive Sales Representative at Takeda, Rene was a top performer during her six-year tenure in Takeda’s Neuroscience Division. Rene holds a Bachelor of Arts degree from Florida International University and is also a Registered Nurse with the Florida Board of Nursing.
When asked about the recent change and movement of Carol Ogg to the Board of Advisors, Barker explains, “We have been so lucky as a startup to have the talented and professional Carol Ogg for years of passionate dedication as our consultant and sales strategist. We are truly honored to have her not only mentor Rene but join our Board of Advisors, continuing our relationship well into the next phase of the company.”
“I’ve had the privilege of providing guidance to ThinkGenetic since its inception and I am so thrilled to be working with Rene to spread the mission,” said Carol Ogg, BS Pharm. “I look forward to joining the ThinkGenetic Board of Advisors and advising the company during an incredibly exciting time in its growth.”
To stay up to date on the latest business developments of ThinkGenetic and the company’s progress, please visit https://thinkgenetic.com.
Download Press Release [PDF]